Ethylnorepinephrine

Ethylnorepinephrine is a sympathomimetic amine that is structurally related to norepinephrine. It is used primarily as a vasopressor and bronchodilator in medical settings.
Chemical Structure and Properties[edit]
Ethylnorepinephrine is a synthetic derivative of norepinephrine, with an ethyl group attached to the nitrogen atom. This modification enhances its stability and duration of action compared to norepinephrine. The chemical formula of ethylnorepinephrine is C10H15NO3.
Pharmacology[edit]
Ethylnorepinephrine acts on adrenergic receptors, primarily stimulating alpha-adrenergic receptors and beta-adrenergic receptors. This dual action results in both vasoconstriction and bronchodilation, making it useful in treating conditions such as hypotension and bronchospasm.
Mechanism of Action[edit]
By stimulating alpha-adrenergic receptors, ethylnorepinephrine causes vasoconstriction, which increases blood pressure. Its action on beta-adrenergic receptors leads to relaxation of bronchial smooth muscles, thereby dilating the airways and improving airflow in patients with bronchospasm.
Medical Uses[edit]
Ethylnorepinephrine is used in the management of:
- Hypotension: To increase blood pressure in patients with acute hypotensive states.
- Bronchospasm: To relieve bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Side Effects[edit]
Common side effects of ethylnorepinephrine include:
Contraindications[edit]
Ethylnorepinephrine should not be used in patients with:
History[edit]
Ethylnorepinephrine was developed as a synthetic alternative to norepinephrine, with the aim of providing a longer duration of action and improved stability. It has been used in various clinical settings since its introduction.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian